| [1] |
Zhu P, Li J, Li L, Li S, Zhu Y, et al. 2026. Preclinical investigation and clinical trials of Red ginseng as an immunomodulator: a narrative review from 2015 to 2025. |
| [2] |
Ren M, Tao X, Chang H, Bi HC, Lee SM, et al. 2026. Ginsenosides in the management of depression: a comprehensive pharmacological review. |
| [3] |
Qu H, Zhang Y, Wang J, Bi Q, Wei W, et al. 2026. Comprehensive saponin profiling and comparison of ten Panax species using a universal offline two-dimensional LC-MS platform. |
| [4] |
Wang WT, Guo HM, Guo SY, Ou WJ, Gao F, et al. 2026. Improvement of physicochemical and functional properties and potential bioaccessibility of rare ginsenoside Rg3 loaded on modified porous cassava starch. |
| [5] |
Zhou X, Li Z, Xiong L, Zhou Y, Cheng Y, et al. 2026. A novel β-glucosidase from Lacticaseibacillus rhamnosus: Catalytic specificity and efficient production of high-value rare ginsenosides. |
| [6] |
Yang W, Zhou J, Gu Q, Harindintwali JD, Yu X, et al. 2023. Combinatorial enzymatic catalysis for bioproduction of ginsenoside compound K. |
| [7] |
Mohanan P, Yang TJ, Song YH. 2023. Genes and regulatory mechanisms for ginsenoside biosynthesis. |
| [8] |
Gwak YS, Han JY, Adhikari PB, Ahn CH, Choi YE. 2017. Heterologous production of a ginsenoside saponin (Compound K) and its precursors in transgenic tobacco impairs the vegetative and reproductive growth. |
| [9] |
Luo Y, Wang P, Wang R, Hui J, Zhu C, et al. 2026. Efficient biosynthesis of rare ginsenoside Compound K using engineered Pichia pastoris with surface-anchored Sulfolobus solfataricus β-glucosidase. |
| [10] |
Yuan W, Jiang C, Wang Q, Fang Y, Wang J, et al. 2022. Biosynthesis of mushroom-derived type II ganoderic acids by engineered yeast. |
| [11] |
Wang Q, Li Y, Zhang S, Yuan W, Du Z, et al. 2025. Decoding and reprogramming of the biosynthetic networks of mushroom-derived bioactive type II ganoderic acids in yeast. |
| [12] |
Xu Z, Xu J, Ji A, Zhu Y, Zhang X, et al. 2015. Genome-wide selection of superior reference genes for expression studies in Ganoderma lucidum. |
| [13] |
Azi F, Dai X, Hong Y, Yin L, Dong M, et al. 2025. Sustainable bioproduction of triterpenoid sapogenins and meroterpenoids in a metabolically engineered medicinal mushroom. |
| [14] |
Xu JW, Ji SL, Li HJ, Zhou JS, Duan YQ, et al. 2015. Increased polysaccharide production and biosynthetic gene expressions in a submerged culture of Ganoderma lucidum by the overexpression of the homologous α-phosphoglucomutase gene. |
| [15] |
Qin H, Xiao H, Zou G, Zhou Z, Zhong JJ. 2017. CRISPR-cas9 assisted gene disruption in the higher fungus Ganoderma species. |
| [16] |
Ganzlin M, Rinas U. 2008. In-depth analysis of the Aspergillus Niger glucoamylase (glaA) promoter performance using high-throughput screening and controlled bioreactor cultivation techniques. |
| [17] |
Song HY, Choi D, Han DM, Kim DH, Kim JM. 2018. A novel rapid fungal promoter analysis system using the phosphopantetheinyl transferase gene, npgA, in Aspergillus nidulans. |
| [18] |
Zhang J, Zhang Y, Zhong Y, Qu Y, Wang T. 2012. Ras GTPases modulate morphogenesis, sporulation and cellulase gene expression in the cellulolytic fungus Trichoderma Reesei. |
| [19] |
Yuan G, Serrano-Zayas T, Dai Z, DeMers EI, Deng S, et al. 2025. Strong translation elongation factor 1-alpha (Tef1α) promoter reporter systems for Aspergillus niger. |
| [20] |
Martín JF, Kosalková K, Liras P. 2026. The global regulator laeA controls expression of genes involved in diverse primary and secondary metabolites biosynthesis and their secretion in fungi. |
| [21] |
Luo Q, Li N, Xu JW. 2022. A methyltransferase laeA regulates ganoderic acid biosynthesis in Ganoderma lingzhi. |
| [22] |
Engler C, Kandzia R, Marillonnet S. 2008. A one Pot, one Step, precision cloning method with high throughput capability. |
| [23] |
Engler C, Gruetzner R, Kandzia R, Marillonnet S. 2009. Golden gate shuffling: a one-pot DNA shuffling method based on type IIs restriction enzymes. |
| [24] |
Zhou L, Li ZK, Li CY, Liang YQ, Yang F. 2022. Anticancer properties and pharmaceutical applications of ginsenoside compound K: a review. |
| [25] |
Yan X, Fan Y, Wei W, Wang P, Liu Q, et al. 2014. Production of bioactive ginsenoside compound K in metabolically engineered yeast. |
| [26] |
Wang P, Wang J, Zhao G, Yan X, Zhou Z. 2021. Systematic optimization of the yeast cell factory for sustainable and high efficiency production of bioactive ginsenoside compound K. |